Related Experiment Video
Updated: May 6, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Successful Volume Control of Invasive Pituitary Adenoma Tumor With Pasireotide: A New Horizon for a Challenging
Tarik Elhadd1, Shahd I Ibrahim1, Elabbass Abdelmahmuod1
1Pituitary Clinic, Endocrine Section, Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.
Abstract:
A 62-year-old Sudanese female was diagnosed with a nonfunctioning pituitary adenoma in 2006. Despite undergoing 3 transsphenoidal surgeries and radiotherapy, her tumor persisted, causing debilitating symptoms, including headaches and visual defects. As a last resort, she was treated with pasireotide, a second-generation somatostatin analog with a broader receptor affinity than first-generation drugs. Over 6 months, the tumor mass was stabilized, and her symptoms, including headaches, disappeared. This case demonstrates a potential new therapeutic possibility for treating resistant pituitary adenoma with pasireotide, offering hope for patients when traditional treatments fail.
Related Concept Videos
The Pituitary Gland
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology

